Silverfin false false 31/12/2025 18/12/2024 31/12/2025 Andrew Macdowell 18/12/2024 Rebecca Macdowell 18/12/2024 Charlotte Macdowell 18/12/2024 Alice Macdowell 18/12/2024 Henry Macdowell 18/12/2024 Andrew David Macdowell 17 September 2026 The principal activity of the company during the financial period was providing medical consultancy services. 16141915 2025-12-31 16141915 bus:Director1 2025-12-31 16141915 bus:Director2 2025-12-31 16141915 bus:Director3 2025-12-31 16141915 bus:Director4 2025-12-31 16141915 bus:Director5 2025-12-31 16141915 core:CurrentFinancialInstruments 2025-12-31 16141915 core:ShareCapital 2025-12-31 16141915 core:RetainedEarningsAccumulatedLosses 2025-12-31 16141915 core:ComputerEquipment 2024-12-17 16141915 2024-12-17 16141915 core:ComputerEquipment 2025-12-31 16141915 bus:OrdinaryShareClass1 2025-12-31 16141915 2024-12-18 2025-12-31 16141915 bus:FilletedAccounts 2024-12-18 2025-12-31 16141915 bus:SmallEntities 2024-12-18 2025-12-31 16141915 bus:AuditExemptWithAccountantsReport 2024-12-18 2025-12-31 16141915 bus:PrivateLimitedCompanyLtd 2024-12-18 2025-12-31 16141915 bus:Director1 2024-12-18 2025-12-31 16141915 bus:Director2 2024-12-18 2025-12-31 16141915 bus:Director3 2024-12-18 2025-12-31 16141915 bus:Director4 2024-12-18 2025-12-31 16141915 bus:Director5 2024-12-18 2025-12-31 16141915 bus:Director6 2024-12-18 2025-12-31 16141915 core:ComputerEquipment core:TopRangeValue 2024-12-18 2025-12-31 16141915 core:ComputerEquipment 2024-12-18 2025-12-31 16141915 bus:OrdinaryShareClass1 2024-12-18 2025-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 16141915 (England and Wales)

MACDOWELL MEDICAL SERVICES LTD

Unaudited Financial Statements
For the financial period from 18 December 2024 to 31 December 2025
Pages for filing with the registrar

MACDOWELL MEDICAL SERVICES LTD

Unaudited Financial Statements

For the financial period from 18 December 2024 to 31 December 2025

Contents

MACDOWELL MEDICAL SERVICES LTD

STATEMENT OF FINANCIAL POSITION

As at 31 December 2025
MACDOWELL MEDICAL SERVICES LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 December 2025
Note 31.12.2025
£
Fixed assets
Tangible assets 3 2,325
2,325
Current assets
Debtors 4 29,713
Cash at bank and in hand 157,797
187,510
Creditors: amounts falling due within one year 5 ( 49,290)
Net current assets 138,220
Total assets less current liabilities 140,545
Net assets 140,545
Capital and reserves
Called-up share capital 6 100
Profit and loss account 140,445
Total shareholders' funds 140,545

For the financial period ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of MacDowell Medical Services Ltd (registered number: 16141915) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Andrew David Macdowell
Director

17 September 2026

MACDOWELL MEDICAL SERVICES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 18 December 2024 to 31 December 2025
MACDOWELL MEDICAL SERVICES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 18 December 2024 to 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

MacDowell Medical Services Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 The Atrium Phoenix Square, Wyncolls Road, Colchester, CO4 9AS, United Kingdom.

The Company was incorporated on 18 December 2024 and commenced trading in January 2025.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the reporting date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the reporting date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Income Statement in respect of pension costs and other post-retirement benefits is the contributions payable in the financial period. Differences between contributions payable in the financial period and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in the Income Statement as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

Period from
18.12.2024 to
31.12.2025
Number
Monthly average number of persons employed by the Company during the period, including directors 5

3. Tangible assets

Computer equipment Total
£ £
Cost
At 18 December 2024 0 0
Additions 2,793 2,793
At 31 December 2025 2,793 2,793
Accumulated depreciation
At 18 December 2024 0 0
Charge for the financial period 468 468
At 31 December 2025 468 468
Net book value
At 31 December 2025 2,325 2,325

4. Debtors

31.12.2025
£
Trade debtors 15,302
Amounts owed by directors 14,411
29,713

5. Creditors: amounts falling due within one year

31.12.2025
£
Trade creditors 3,983
Taxation and social security 45,206
Other creditors 101
49,290

6. Called-up share capital

31.12.2025
£
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100

7. Related party transactions

Transactions with the entity's directors

During the year advances of £14,630 were made to a director. These were repayable on demand and interest was charged on the amounts.

Amounts repaid by a director during the year totalled £219.

At the year end the Company was owed £14,411 by a director.